About this trial
The goal of this clinical trial is to test how storage temperature of deceased donor kidneys affects kidney function after transplant in adult patients receiving a kidney transplant.
The main question it aims to answer is:
• Do patients that receive a kidney transplant stored at 10 °C have improved post-transplant kidney function? Researchers will compare patients who receive kidneys stored at 10 °C versus kidneys stored at 4°C (on ice, i.e. conventional storage) to see if kidneys stored at 10 °C have improved function.
Participants will:
* Be made aware of and consent to receive a kidney transplant that had been stored at 10 °C * Have their urine collected 24 hours after surgery to be analyzed for research
Eligibility criteria
Qualifiers
None
Disqualifiers
Kidney transplant candidates less than 18 years old
Kidney transplant candidates that decline consent
Transplant candidates listed for multi-organ transplant
Donation after brain death or donation after circulatory death kidney donors, whose health care proxy has consented for donation and the possibility of research
Trial design
Treatments tested in this trial
- 10˚C deceased donor kidney storage using Traferox XPort
Treatment groups
Sponsors and collaborators
Vanderbilt University Medical Center
Lead sponsor
Traferox Technology Inc.
Collaborator